Phyton Biotech
Maxwell Lea has extensive experience in the healthcare and pharmaceuticals sectors, currently serving as Managing Director at DFB Pharmaceuticals LLC since 2013. In this role, Maxwell oversees the development of new products and businesses, leveraging a successful track record in start-ups and strategic acquisitions. Prior to this, Maxwell held several leadership positions, including Vice President of Corporate Development at DFB Pharmaceuticals Inc. and Vice President of Business Development & International at Healthpoint Biotherapeutics. Maxwell has also contributed to corporate finance and investment banking during tenure at DFB Pharmaceuticals Inc. and Banc of America Securities LLC. Academically, Maxwell holds an MBA from Duke University's Fuqua School of Business and a BA in Economics from Vanderbilt University.
This person is not in any teams
Phyton Biotech
Phyton Biotech is the world’s leader in pharmaceutical plant cell fermentation (PCF®) technology. A global supplier of high-quality oncology actives via PCF, their products are registered in every major country in the world.